Becton, Dickinson and Co. | BDX - Selling And Administration Expenses

Stock Price
159.36
Daily Change
-0.27 -0.17%
Monthly
-10.16%
Yearly
-29.48%
Q1 Forecast
154.55

Becton, Dickinson and Co. reported $1.39B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 476M 48M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
AngioDynamics USD 35.99M 14K Feb/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 383M 28M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
J&J USD 6.75B 831M Dec/2025
Masimo USD 128M 11.6M Dec/2025
Medtronic 2.97B 159M Sep/2025
Solventum Corp USD 759M 15M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025